Response to intraarterial induction chemotherapy: A prognostic parameter in oral and oropharyngeal cancer

Head and Neck

Volumn 28, Issue 8, 2006, Pages 678-688

  Kovács, Adorján F ^a  

^a GOETHE UNIVERSITY MEDICAL SCHOOL   (Germany)

Author keywords

Cisplatin; Head and neck cancer; Intraarterial chemotherapy; Oral cancer; Prognosis

Indexed keywords

CISPLATIN; DOLASETRON MESILATE; FLUOROURACIL; HEPARIN; MEPIVACAINE; PREDNISOLONE; SODIUM THIOSULFATE;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ALOPECIA; ANEMIA; ARTICLE; CANCER CHEMOTHERAPY; DIARRHEA; DRUG MEGADOSE; FEMALE; HEAD AND NECK CANCER; HUMAN; HYPERGLYCEMIA; HYPERURICEMIA; HYPOACUSIS; HYPOKALEMIA; KAPLAN MEIER METHOD; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; MOLECULAR GENETICS; MOUTH CANCER; NAUSEA; OROPHARYNX CANCER; OVERALL SURVIVAL; PAIN; PATHOLOGICAL ANATOMY; PRIORITY JOURNAL; PROGNOSIS; SWELLING; THROMBOCYTOPENIA; UREMIA;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; COMBINED MODALITY THERAPY; FEMALE; HUMANS; INFUSIONS, INTRA-ARTERIAL; MALE; MIDDLE AGED; MOUTH NEOPLASMS; OROPHARYNGEAL NEOPLASMS; PROGNOSIS; RADIOTHERAPY, ADJUVANT;

EID: 33746326855     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.20388     Document Type: Article

References (19)

1. Schantz SP, Harrison LB, Forastiere AA. Tumors of the nasal cavity and paranasal sinuses, nasopharynx, oral cavity, and oropharynx. In: DeVita VT, Hellman S, Rosenberg SA, editors. Cancer: principles & practice of oncology. 6th ed. Philadelphia: Lippincott Williams & Wilkins, 2001. p 812.
2. Korogi Y, Hirai T, Nishimura R, et al. Superselective intraarterial infusion of cisplatin for squamous cell carcinoma of the mouth: preliminary clinical experience. AJR Am J Roentgenol 1995;165:1269-1272.
3. Hirai T, Korogi Y, Hamatake S, et al. Stages III and IV squamous cell carcinoma of the mouth: three-year experience with superselective intraarterial chemotherapy using cisplatin prior to definitive treatment. Cardiovasc Intervent Radiol 1999;22:201-205.
4. Benazzo M, Caracciolo G, Zappoli F, Bernardo G, Mira E. Induction chemotherapy by superselective intra-arterial high-dose carboplatin infusion for head and neck cancer. Eur Arch Otorhinolaryngol 2000;257:279-282.
5. Damascelli B, Patelli GL, Lanocita R, et al. A novel intraarterial chemotherapy using paclitaxel in albumin nano-particles to treat advanced squamous cell carcinoma of the tongue: preliminary findings. AJR Am J Roentgenol 2003;181:253-260.
6. Kovács AF, Turowski B, Ghahremani MT, Loitz M. Intraarterial chemotherapy as neoadjuvant treatment of oral cancer. J Craniomaxillofac Surg 1999;27:302-307.
7. Kovács AF. Intraarterial chemotherapy and chemoembolization in head and neck cancer. Establishment as a neoadjuvant routine method. Cancer Therapy 2003;1:1-9 (http://www.cancer-therapy.org/).
8. Robbins KT, Storniolo AM, Kerber C, et al. Phase I study of highly selective supradose cisplatin infusions for advanced head and neck cancer. J Clin Oncol 1994;2:2113-2120.
9. Robbins KT, Kumar P, Wong FS, et al. Targeted chemoradiation for advanced head and neck cancer: analysis of 213 patients. Head Neck 2000;22:687-693.
10. Kovács AF, Obitz P, Wagner M. Monocomponent chemoembolization in oral and oropharyngeal cancer using an aqueous crystal suspension of cisplatin. Br J Cancer 2002;86:196-202.
11. Kovács AF. Mundhöhlen und Oropharynxkarzinome Neue Mittel und Wege der Therapie. Norderstedt: Books on Demand; 2003.
12. Kovács AF. Intra-arterial induction high-dose chemotherapy with cisplatin for oral and oropharyngeal cancer: long-term results. Br J Cancer 2004;90:1323-1328.
13. Tegeder I, Bräutigam L, Seegel M, et al. Cisplatin tumor concentrations after intra-arterial cisplatin infusion or embolization in patients with oral cancer. Clin Pharmacol Ther 2003;73:417-426.
14. Miller AB, Hoogstraten B, Staquet M, Winkler A. Reporting results of cancer treatment. Cancer 1981;47:207-214.
15. Bier J. Definitionen zum radikalchirurgischen Vorgehen bei Plattenepithelkarzinomen der Mundhöhle. Deutsch-Österreichisch- Schweizerischer Arbeitskreis für Tumoren im Kiefer und Gesichtsbereich (DÖSAK). Dtsch Z Mund-Kiefer-GesichtsChir 1982;6:369-372.
16. Seegenschmiedt MH. Interdisciplinary documentation of treatment side effects in oncology. Present status and perspectives. Strahlenther Onkol 1998;174(Suppl 3):S25-S29.
17. Kaplan E, Meier P. Nonparametric estimation, from incomplete observations. J Am Stat Assoc 1958;53:457-481.
18. Molinari R, Chiesa F, Cantù G, Costa L, Grandi C, Sala L. Prognostic factors in cancer of the oral cavity and anterior oropharynx treated with preliminary neoadjuvant intra-arterial chemotherapy followed by surgery. In: Eckardt A, editor. Intra-arterial chemotherapy in head and neck cancer-current results and future perspectives. Reinbek: Eichhorn-Presse Verlag; 1999. p 148-161.
19. Kitagawa Y, Nishizawa S, Sano K, et al. Prospective comparison of 18F-FDG PET with conventional imaging modalities (MRI, CT, and 67Ga scintigraphy) in assessment of combined intraarterial chemotherapy and radiotherapy for head and neck carcinoma. J Nucl Med 2003;44:198-206.